YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer Inc. is considering a merger of its off-patent drug business with generic drugmaker Mylan, people familiar with the matter told The Wall Street Journal.
Under the proposal, Mylan shareholders would own more than 40% of the new entity and Pfizer shareholders would own the remainder.
Such a deal would create a global company that sells lower-priced pharmaceuticals.
Read more from The Wall Street Journal.
There is unlimited potential in downtown Springfield, and it’s all coming together right now. That’s the assessment of Rusty Worley, executive director of the Downtown Springfield Association, as he considers the many projects that are now coalescing around the city’s center.